This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
ImmunoGen, Inc. : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 116.7% over the last 60 days.
Aquestive Therapeutics, Inc. (AQST - Free Report) : This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 72% over the last 60 days.
Burford Capital Limited (BUR - Free Report) : This company which provides legal finance products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 16% over the last 60 days.
Guidewire Software, Inc. (GWRE - Free Report) : This insurance technology solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 10.5% over the last 60 days.
Veeco Instruments Inc. (VECO - Free Report) : This semiconductor equipment manufacturer has seen the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.2% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Get the latest research report on VECO - FREE
Get the latest research report on GWRE - FREE
Get the latest research report on BUR - FREE
Get the latest research report on AQST - FREE